Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Effect of acquired drug resistant TB emergence during SCC on treatment failure

From: Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis

Time of acquired drug resistance emergence Total Treatment success n(%) Treatment failure n(%) Univariate analysis
     OR(95 % CI) P value
2 months 52 44(84.6) 6(11.5) Reference <0.001*
3–5 months 10 2(20.0) 7(70.0) 25.7(4.3–153.4)  
  1. * P value was determined by Fisher’s Exact Test